瑞信-美股-制药业-美国制药业预览

瑞信-美股-制药业-美国制药业预览

ID:8229775

大小:3.75 MB

页数:110页

时间:2018-03-11

瑞信-美股-制药业-美国制药业预览_第1页
瑞信-美股-制药业-美国制药业预览_第2页
瑞信-美股-制药业-美国制药业预览_第3页
瑞信-美股-制药业-美国制药业预览_第4页
瑞信-美股-制药业-美国制药业预览_第5页
资源描述:

《瑞信-美股-制药业-美国制药业预览》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库

1、USPharmaceuticalsPolitics,PipelineandNewProductsinFocus;PreferMRK,AGNandJNJforLarge-Caps;ALKS,AIMTandMYOKinSMIDBottomLine:Inthefinalquarterof2017,weanticipateinvestorswillcontinuetokeepaneyeonmacroOctober2017issuessuchasU.S.drugpricingandpotentialU.S.corporatetaxref

2、orm,althoughasignificantamountofproductnewsshouldalsoimpacthowinvestorsviewthevariousnames.Overall,webelievesentimentonthegroupremainsrelativelyrobustwithnoiseonthedrugpricingsidefarbelowwhatithasbeenandRESEARCHANALYSTSinvestorsstillcautiouslyoptimisticonthepossibil

3、ityofcorporatetaxreformcomingthroughin2018.VamilDivan,MDDependingonhowtheseissuesplayout,itcouldalsoleadtoincreasedexcitementaroundpotential(212)538-5394businessdevelopmentandM&Ainthesector,aswebelievemostofourlargecapcompaniesarestillvamil.divan@credit-suisse.comwa

4、itingforfurtherclarityontheseissuesbeforeannouncingtransformativedeals.Inadditiontoprovidingnewgrowthdriverstoourlargecapcompanies,businessdevelopmenteffortswillalsolikelyboostinterestinourSMIDcapnamesthatcouldbepotentialtargets.OntheproductsidewehaveimportantdataMi

5、chaelV.Morabito,Ph.D.releasesexpectedbyyearendinlargemarketssuchasoncology/immuno-oncology,rheumatoidarthritis(212)325-7298andpsoriasis,aswellasinmorespecializedmarketssuchaspeanutallergy.michael.morabito@credit-suisse.comPreferMRK,AGNandJNJinlargecap.WeviewMRKasour

6、TopPickinouruniverseasweexpectKeytrudatobeatexpectationsanddriveupsidethroughthecourseoftheyear,althoughtheirrecoveryfromtherecentcyber-attackbearswatching.SentimentaroundAGNremainssplitbutweassumefurtherBarbaraKoteistabilityinthebasebusinessandimprovingcashflowsand

7、earningsqualityshouldallowforfocustoshift(212)538-8119totheoptionalityinthepipelinelaterintheyear,especiallyoncewehavesomeclarityontheRestasisbarbara.kotei@credit-suisse.compatentsituation.WeseeJNJ’sPharmaceuticalsSegmentdrivingupsideforthecompany,specificallyproduc

8、tssuchasXarelto,Darzalex,Imbruvica,andtheschizophreniafranchise.DuaaMohamedSeeopportunitiesinSMIDcap,ledbyALKS,AIMTandMYOK.Vivitrolremains

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。